Mirae Asset Global Investments’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $320K | Buy |
2,495
+404
| +19% | +$51.8K | ﹤0.01% | 994 |
|
|
2025
Q1 | $186K | Sell |
2,091
-26
| -1% | -$2.31K | ﹤0.01% | 1058 |
|
|
2024
Q4 | $189K | Sell |
2,117
-174
| -8% | -$15.6K | ﹤0.01% | 1054 |
|
|
2024
Q3 | $212K | Buy |
2,291
+422
| +23% | +$39.1K | ﹤0.01% | 1083 |
|
|
2024
Q2 | $203K | Sell |
1,869
-32,663
| -95% | -$3.54M | ﹤0.01% | 1046 |
|
|
2024
Q1 | $1.72M | Sell |
34,532
-2,882
| -8% | -$144K | ﹤0.01% | 1273 |
|
|
2023
Q4 | $3.45M | Buy |
37,414
+145
| +0.4% | +$13.4K | 0.01% | 1028 |
|
|
2023
Q3 | $1.87M | Buy |
37,269
+1,417
| +4% | +$71.2K | ﹤0.01% | 1202 |
|
|
2023
Q2 | $2.28M | Sell |
35,852
-1,476
| -4% | -$93.9K | ﹤0.01% | 1154 |
|
|
2023
Q1 | $1.68M | Buy |
37,328
+7,090
| +23% | +$319K | ﹤0.01% | 1294 |
|
|
2022
Q4 | $1.32M | Buy |
30,238
+63
| +0.2% | +$2.76K | ﹤0.01% | 1343 |
|
|
2022
Q3 | $1.99M | Buy |
30,175
+8,935
| +42% | +$589K | 0.01% | 1140 |
|
|
2022
Q2 | $1.07M | Buy |
+21,240
| New | +$1.07M | ﹤0.01% | 1367 |
|
|
2021
Q4 | – | Sell |
-123,042
| Closed | -$12.7M | – | 1591 |
|
|
2021
Q3 | $12.7M | Buy |
123,042
+24,058
| +24% | +$2.47M | 0.03% | 554 |
|
|
2021
Q2 | $8.71M | Buy |
98,984
+32,635
| +49% | +$2.87M | 0.02% | 691 |
|
|
2021
Q1 | $6.45M | Buy |
66,349
+28,826
| +77% | +$2.8M | 0.02% | 674 |
|
|
2020
Q4 | $4.21M | Buy |
37,523
+6,722
| +22% | +$754K | 0.02% | 695 |
|
|
2020
Q3 | $2.86M | Buy |
30,801
+9,731
| +46% | +$902K | 0.01% | 686 |
|
|
2020
Q2 | $1.64M | Buy |
21,070
+8,940
| +74% | +$698K | 0.01% | 751 |
|
|
2020
Q1 | $710K | Buy |
12,130
+1,193
| +11% | +$69.8K | 0.01% | 922 |
|
|
2019
Q4 | $876K | Buy |
10,937
+1,409
| +15% | +$113K | 0.01% | 999 |
|
|
2019
Q3 | $700K | Buy |
9,528
+6,120
| +180% | +$450K | ﹤0.01% | 1047 |
|
|
2019
Q2 | $322K | Buy |
+3,408
| New | +$322K | ﹤0.01% | 1261 |
|